CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Option exercise | +2,563 | 25,463 | ||
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Shares withheld for taxes | −1,836 | $8.27 | $15K | 23,627 |
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Option exercise · Restricted Stock Units | −5,900 | 5,900 | ||
| 2023-03-16 | Ottinger Bradley General Counsel and CCO | Option exercise · Restricted Stock Units | −2,563 | 2,564 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise | +8,250 | 34,208 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise | +3,000 | 37,208 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise | +2,500 | 39,708 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Shares withheld for taxes | −2,196 | $8.27 | $18K | 37,512 |
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Shares withheld for taxes | −778 | $8.27 | $6K | 36,734 |
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Shares withheld for taxes | −933 | $8.27 | $8K | 35,801 |
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −8,250 | 8,250 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −3,000 | 3,000 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Option exercise · Restricted Stock Units | −2,500 | 2,500 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Grant or award · Employee Stock Option (right to purchase) | +78,000 | 78,000 | ||
| 2023-03-16 | Scopelianos Angelo Chief R&D Officer | Grant or award · Restricted Stock Units | +54,100 | 54,100 | ||
| 2023-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Option exercise | +5,500 | 67,445 | ||
| 2023-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Shares withheld for taxes | −1,866 | $8.27 | $15K | 65,579 |
| 2023-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Option exercise | +15,250 | 80,829 | ||
| 2023-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Shares withheld for taxes | −5,172 | $8.27 | $43K | 75,657 |
| 2023-03-16 | MARIANI PETER J EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −5,500 | 5,500 |
Page 20 of 69 · 1,376 trades